METTL3 and acute myeloid leukemia: METTL3 not only activates the oncogene c-MYC by enhancing the m6A modification of SP1 (13), it also promotes the translation of BCL2 and PTEN mRNA through the up-regulation of their m6A modification (14), which ultimately leads to the development of AML.